Our study therefore identifies a cellular mechanism whereby deficient microglia drive pathology in rnaset2 mutants and supports a cellular approach to targeting microglia dysfunction in RNASET2-deficient leukodystrophy, beyond the genetic strategies previously explored. Here, RNASET2 is linked to leukodystrophy.